Placenta Antibody

Placenta Antibody

Placenta Lysate

21-469 ProSci 0.1 mg 342.6 EUR
Description: Rat placenta tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The rat placenta tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the placenta tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The placenta tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Rat Placenta PrimaCell: Normal Placenta Amniotic Cells

2-82579 CHI Scientific 1 Kit Ask for price

Human Placenta PrimaCell: Normal Placenta Amniotic Cells

2-96098 CHI Scientific 1 Kit Ask for price

Placenta Growth Factor (PLGF) Antibody

20-abx142140 Abbexa
  • 444.00 EUR
  • 727.20 EUR
  • 376.80 EUR
  • 100 ul
  • 200 ul
  • 50 ul

Placenta Growth Factor (PLGF) Antibody

20-abx102283 Abbexa
  • 360.00 EUR
  • 159.60 EUR
  • 961.20 EUR
  • 510.00 EUR
  • 309.60 EUR
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody

20-abx102284 Abbexa
  • 376.80 EUR
  • 159.60 EUR
  • 1028.40 EUR
  • 526.80 EUR
  • 326.40 EUR
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody

20-abx102285 Abbexa
  • 510.00 EUR
  • 159.60 EUR
  • 1412.40 EUR
  • 693.60 EUR
  • 393.60 EUR
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Growth Factor (PGF) Antibody

20-abx001442 Abbexa
  • 493.20 EUR
  • 710.40 EUR
  • 218.40 EUR
  • 376.80 EUR
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Placenta Growth Factor (PGF) Antibody

abx028155-400ul Abbexa 400 ul 627.6 EUR

Placenta Growth Factor (PGF) Antibody

abx028155-80l Abbexa 80 µl 343.2 EUR

Placenta Growth Factor (PGF) Antibody

20-abx306392 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody

abx433146-200ul Abbexa 200 ul 460.8 EUR

Placenta Growth Factor (PLGF) Antibody

20-abx174070 Abbexa
  • 844.80 EUR
  • 427.20 EUR
  • 1 mg
  • 200 ug

Placenta Growth Factor (PLGF) Antibody

20-abx174071 Abbexa
  • 1011.60 EUR
  • 526.80 EUR
  • 1 mg
  • 200 ug

Placenta Growth Factor (PLGF) Antibody

20-abx178023 Abbexa
  • 1362.00 EUR
  • 661.20 EUR
  • 1 mg
  • 200 ug

Placenta Growth Factor (PLGF) Antibody

20-abx178024 Abbexa
  • 1545.60 EUR
  • 744.00 EUR
  • 1 mg
  • 200 ug

Ferritin, Human Placenta

P1451-50 Biovision 301.2 EUR

Placenta Ribonuclease Inhibitor

Z5040001 Biochain 5000 units 379.2 EUR
Description: Working with the fragile RNA molecules requires a great deal of caution, especially when it comes to protecting them from all the RNases that are virtually everywhere. Ensure a successful reverse transcription PCR by protecting you RNAs with our RNase inhibitor.

Placenta Membrane Lysate

XBL-10819 ProSci 0.1 mg 619.8 EUR
Description: Human placenta tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human placenta tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated placenta tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated placenta tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Rat Placenta PrimaCell: Normal Placenta Amniotic Cells Growth Medium

9-25079 CHI Scientific 5 x 100 ml Ask for price

Human Placenta PrimaCell: Normal Placenta Amniotic Cells Growth Medium

9-46098 CHI Scientific 5 x 100 ml Ask for price

Human Placenta Tissue Preparation Buffer: Normal Placenta Amniotic Cells

9-80098 CHI Scientific 1 x 100 ml Ask for price

Rat Placenta Tissue Preparation Buffer: Normal Placenta Amniotic Cells

9-80286 CHI Scientific 1 x 100 ml Ask for price

Placenta Specific Protein 9 (PLAC9) Antibody

20-abx132127 Abbexa
  • 427.20 EUR
  • 1111.20 EUR
  • 560.40 EUR
  • 184.80 EUR
  • 326.40 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 9 (PLAC9) Antibody

20-abx102925 Abbexa
  • 543.60 EUR
  • 159.60 EUR
  • 1579.20 EUR
  • 744.00 EUR
  • 410.40 EUR
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta-Specific Protein 4 (PLAC4) Antibody

abx028782-400ul Abbexa 400 ul 627.6 EUR

Placenta-Specific Protein 4 (PLAC4) Antibody

abx028782-80l Abbexa 80 µl 343.2 EUR

Placenta-Specific Protein 1 (PLAC1) Antibody

abx030937-400ul Abbexa 400 ul 627.6 EUR

Placenta-Specific Protein 1 (PLAC1) Antibody

abx030937-80l Abbexa 80 µl 343.2 EUR

Placenta-Specific Protein 1 (PLAC1) Antibody

abx036602-100ug Abbexa 100 ug 469.2 EUR

Insulin-Like 4 (Placenta) (INSL4) Antibody

abx036652-100ug Abbexa 100 ug 469.2 EUR

Insulin-Like 4 (Placenta) (INSL4) Antibody

20-abx249451 Abbexa
  • 376.80 EUR
  • 117.60 EUR
  • 477.60 EUR
  • 594.00 EUR
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Placenta Specific Protein 9 (PLAC9) Antibody

20-abx307413 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody (FITC)

20-abx271259 Abbexa
  • 393.60 EUR
  • 260.40 EUR
  • 1111.20 EUR
  • 560.40 EUR
  • 343.20 EUR
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody (Biotin)

20-abx271525 Abbexa
  • 393.60 EUR
  • 260.40 EUR
  • 1045.20 EUR
  • 543.60 EUR
  • 326.40 EUR
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Growth Factor (PGF) Antibody (HRP)

20-abx306393 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Growth Factor (PGF) Antibody (FITC)

20-abx306394 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Growth Factor (PGF) Antibody (Biotin)

20-abx306395 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Insulin-Like 4 (Placenta) (INSL4) Antibody

20-abx307015 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 8 (PLAC8) Antibody

20-abx313859 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Insulin-Like 4 (Placenta) (INSL4) Antibody

20-abx324864 Abbexa
  • 376.80 EUR
  • 292.80 EUR
  • 100 ug
  • 50 ug

Placenta-Specific Protein 1 (PLAC1) Antibody

20-abx310990 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 8 (PLAC8) Antibody

abx236511-100ug Abbexa 100 ug 577.2 EUR

Plgf Antibody / Pgf / Placenta growth factor

R32889 NSJ Bioreagents 100 ug 419 EUR

PLAC9 Antibody / Placenta-specific protein 9

RQ4388 NSJ Bioreagents 100 ug 419 EUR

PLGF Antibody / PGF / Placenta Growth Factor

RQ4653 NSJ Bioreagents 100ug 419 EUR

PLGF Antibody / PGF / Placenta Growth Factor

V3161-100UG NSJ Bioreagents 100 ug 499 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include Fibroblast Growth Factor (FGF), Platelet Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PLGF). Placenta growth factor (PLGF) is a secreted protein primarily produced by placental trophoblasts but also expressed in other endothelial cells and tumors. There are three isoforms, PLGF-1, PLGF-2, and PLGF-3. PLGF-2 is expressed up until week 8 in the placenta; the placental tissues continuously express PLGF-1 and PLGF-3 but only PLGF-1 is found in colon and mammary carcinomas. PLGF acts to stimulate angiogenesis, endothelial growth and migration. PLGF is a powerful promoter of tumor growth and is upregulated in some cancers, and PLGF is thought to aid in atherosclerotic lesions and neovascular growth surrounding the lesion. Also, PLGF appears to aid aldosterone mediated atherosclerosis. Serum levels of PLGF in some cases are used as a potential biomarker for disease or genetic defect. Recent research indicates that PLGF levels are lower in mothers with Down syndrome fetuses. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor

V3161-20UG NSJ Bioreagents 20 ug 219 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include Fibroblast Growth Factor (FGF), Platelet Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PLGF). Placenta growth factor (PLGF) is a secreted protein primarily produced by placental trophoblasts but also expressed in other endothelial cells and tumors. There are three isoforms, PLGF-1, PLGF-2, and PLGF-3. PLGF-2 is expressed up until week 8 in the placenta; the placental tissues continuously express PLGF-1 and PLGF-3 but only PLGF-1 is found in colon and mammary carcinomas. PLGF acts to stimulate angiogenesis, endothelial growth and migration. PLGF is a powerful promoter of tumor growth and is upregulated in some cancers, and PLGF is thought to aid in atherosclerotic lesions and neovascular growth surrounding the lesion. Also, PLGF appears to aid aldosterone mediated atherosclerosis. Serum levels of PLGF in some cases are used as a potential biomarker for disease or genetic defect. Recent research indicates that PLGF levels are lower in mothers with Down syndrome fetuses. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor

V3161SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include Fibroblast Growth Factor (FGF), Platelet Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PLGF). Placenta growth factor (PLGF) is a secreted protein primarily produced by placental trophoblasts but also expressed in other endothelial cells and tumors. There are three isoforms, PLGF-1, PLGF-2, and PLGF-3. PLGF-2 is expressed up until week 8 in the placenta; the placental tissues continuously express PLGF-1 and PLGF-3 but only PLGF-1 is found in colon and mammary carcinomas. PLGF acts to stimulate angiogenesis, endothelial growth and migration. PLGF is a powerful promoter of tumor growth and is upregulated in some cancers, and PLGF is thought to aid in atherosclerotic lesions and neovascular growth surrounding the lesion. Also, PLGF appears to aid aldosterone mediated atherosclerosis. Serum levels of PLGF in some cases are used as a potential biomarker for disease or genetic defect. Recent research indicates that PLGF levels are lower in mothers with Down syndrome fetuses. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor

V2223-100UG NSJ Bioreagents 100 ug 499 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include fibroblast-, platelet derived-, vascular endothelial- and placenta- growth factor (PLGF). Like vascular endothelial growth factor, several PLGF variants have been shown to arise from alternative mRNA splicings. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor

V2223-20UG NSJ Bioreagents 20 ug 219 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include fibroblast-, platelet derived-, vascular endothelial- and placenta- growth factor (PLGF). Like vascular endothelial growth factor, several PLGF variants have been shown to arise from alternative mRNA splicings. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor

V2223SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include fibroblast-, platelet derived-, vascular endothelial- and placenta- growth factor (PLGF). Like vascular endothelial growth factor, several PLGF variants have been shown to arise from alternative mRNA splicings. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

Human Placenta Ferritin Protein

abx060941-1mg Abbexa 1 mg 1830 EUR

Placenta-Specific 8 Protein

20-abx261180 Abbexa
  • 4101.60 EUR
  • 393.60 EUR
  • 276.00 EUR
  • 1 mg
  • 25 ug
  • 5 ug

Human Placenta Tissue Lysate

LYSATE0022 BosterBio 200ug 180 EUR
Description: This cell lysate is prepared from human placenta tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C.

Placenta Specific Protein 9 (PLAC9) Antibody (HRP)

20-abx307414 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 9 (PLAC9) Antibody (FITC)

20-abx307415 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 9 (PLAC9) Antibody (Biotin)

20-abx307416 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 9 (PLAC9) Antibody (Biotin)

20-abx272460 Abbexa
  • 577.20 EUR
  • 292.80 EUR
  • 1713.60 EUR
  • 811.20 EUR
  • 427.20 EUR
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Insulin-Like 4 (Placenta) (INSL4) Antibody (HRP)

20-abx307016 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Insulin-Like 4 (Placenta) (INSL4) Antibody (FITC)

20-abx307017 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Insulin-Like 4 (Placenta) (INSL4) Antibody (Biotin)

20-abx307018 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 8 (PLAC8) Antibody (HRP)

20-abx313860 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 8 (PLAC8) Antibody (FITC)

20-abx313861 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 8 (PLAC8) Antibody (Biotin)

20-abx313862 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta-Expressed Transcript 1 Protein (Plet1) Antibody

20-abx319341 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta-Specific Protein 1 (PLAC1) Antibody (HRP)

20-abx310991 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta-Specific Protein 1 (PLAC1) Antibody (FITC)

20-abx310992 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta-Specific Protein 1 (PLAC1) Antibody (Biotin)

20-abx310993 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta-Specific 1-Like Protein (PLAC1L) Antibody

abx236510-100ug Abbexa 100 ug 661.2 EUR

Placenta Growth Factor (PLGF) Polyclonal Antibody (Human)

4-PAA114Hu01 Cloud-Clone
  • 236.40 EUR
  • 2077.20 EUR
  • 537.60 EUR
  • 286.80 EUR
  • 231.60 EUR
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Placenta Growth Factor (PLGF)

Placenta Growth Factor (PLGF) Polyclonal Antibody (Mouse)

4-PAA114Mu01 Cloud-Clone
  • 228.00 EUR
  • 1934.40 EUR
  • 505.20 EUR
  • 273.60 EUR
  • 226.80 EUR
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Placenta Growth Factor (PLGF)